ASX Announcement

Neuren completes Phelan-McDermid syndrome Phase 2 trial

Published: 13/11/23, 09:45am (AEST)2 pages
Neuren Pharmaceuticals Limited
NEU:ASXHealthcare

Recent NEU Announcements

Price Sensitive only